Literature DB >> 6406454

Effects of bupropion on body weight.

N Harto-Truax, W C Stern, L L Miller, T L Sato, A E Cato.   

Abstract

Patients' weights were assessed during placebo-controlled, amitriptyline-controlled, and uncontrolled bupropion trials. Low-moderate (50-450 mg/day) to moderate-high (300-750 mg/day) doses of bupropion were consistently associated with a lack of weight gain (average weight loss of 1-2 pounds); placebo was associated with an average weight gain of 1 lb and 75-225 mg/day of amitriptyline was associated with an increase of 3-9 lb. Bupropion treatment was rarely accompanied by reports of appetite change and had no statistically significant effect on caloric intake when compared to placebo.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6406454

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  7 in total

Review 1.  Antiobesity drugs: current and future issues.

Authors:  M Ammar Hatahet; Nikhil V Dhurandhar
Journal:  Curr Diab Rep       Date:  2002-10       Impact factor: 4.810

2.  MSI-1436 reduces acute food intake without affecting dopamine transporter activity.

Authors:  Mitchell F Roitman; Seth Wescott; Jackson J Cone; Michael P McLane; Henry R Wolfe
Journal:  Pharmacol Biochem Behav       Date:  2010-05-15       Impact factor: 3.533

3.  Effect of comedication of bupropion and other antidepressants on body mass index.

Authors:  Priyadarshini P Ravindran; Wenzhao Zang; Swetha Renukunta; Rick Mansour; Srinivas Denduluri
Journal:  Ther Adv Psychopharmacol       Date:  2015-06

4.  Behavioral screen for antidepressants: the effects of drugs and electroconvulsive shock on performance under a differential-reinforcement-of-low-rate schedule.

Authors:  L S Seiden; J L Dahms; R A Shaughnessy
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

5.  A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake Inhibitor.

Authors:  Stephen M. Stahl; James F. Pradko; Barbara R. Haight; Jack G. Modell; Carol B. Rockett; Susan Learned-Coughlin
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2004

6.  Evidence for feeding elicited through antihistaminergic effects of tricyclic antidepressants in the rat hypothalamus.

Authors:  K Ookuma; T Sakata; K Fujimoto
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 7.  Modern pharmacological treatment of obese patients.

Authors:  Marcus May; Christoph Schindler; Stefan Engeli
Journal:  Ther Adv Endocrinol Metab       Date:  2020-01-22       Impact factor: 3.565

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.